护佑品牌怎么样 申请店铺

我要投票 护佑在医疗用品行业中的票数:221 更新时间:2025-05-10
护佑是哪个国家的品牌?「护佑」是 扬子江药业集团有限公司 旗下著名品牌。该品牌发源于江苏省泰州市,由创始人徐镜人在2001-03-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力护佑品牌出海!将品牌入驻外推网,定制护佑品牌推广信息,可以显著提高护佑产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

护佑怎么样

创建于1971年,拥有中西药并举,处方药与非处方药并重的产品体系,产学研/科工贸一体化的创新型医药企业集团


扬子江药业集团创建于1971年,是一家跨地区、产学研相结合、科工贸一体化的国家大型医药企业集团。集团总部位于江苏省泰州市,现有员工15000人,总占地面积300多万平方米。旗下15家成员公司分布泰州、北京、上海、南京、广州、成都、苏州、常州等地;营销网络覆盖除台湾以外的全国各省、市、自治区。

扬子江药业集团把研发创新作为企业发展战略基点,致力于国家一类新药和创新药物的研发。集团坚持不懈走创新之路,在新药研发上,全面推进“三药并举”战略,以每年按销售额3~4%比例投入新药研发,抢占科技制高点,引进具有国际视野的高端研发创新人才,建立国际化研发体系。目前在研的化学创新药、仿制药、中药和生物药达100多个,确保了短期、中期和长期产品研发有序进行。经过多年的积累和创新,产品体系覆盖10多个领域、10多种剂型、200多个品规。集团一直以市场为导向,研发产品以抗感染、心脑血管、消化系统为主,并积极开拓其它具有增长潜力的用药市场,形成“研发一批、生产一批、储备一批”的产品梯队,有力保证了企业的持续健康发展。

集团根据中医泰斗董建华院士等名老中医的验方,相继成功研发并上市胃苏颗粒、荜铃胃痛颗粒、蓝芩口服液、双花百合片、香芍颗粒、百乐眠胶囊、黄芪精口服液、柴芩清宁胶囊、青乳消颗粒、补肾润肺口服液、神曲消食口服液等一大批疗效独特的中药精品,为无数患者送去健康福音。正在建设的龙凤堂中药项目,将致力于药材自动化前处理——智能投料——原辅料、成品无人输送——机器人码垛——自动控温立体高架库储存等技术攻尖,全力打造现代化中药智能工厂。

集团发展不忘回报社会,多年来在赈灾、扶贫、拥军、助学以及各种人道主义救助活动中始终走在全社会的前列。集团至今连续16多年资助“中华医学科技奖”评选,鼎力支持祖国医学科技进步。汶川大地震发、天津港爆炸、盐城龙卷风灾害发生后,扬子江在第一时间捐赠款物,奉献爱心。

面向未来,奋进中的扬子江药业集团以振兴民族医药为己任,怀着科学、严谨、负责的态度,竭诚为全人类的健康服务。


Founded in 1971, Yangzijiang Pharmaceutical Group, an innovative pharmaceutical enterprise group with the integration of production, research, science, industry and trade, is a large-scale national pharmaceutical enterprise group with the integration of science, industry and trade and the combination of production, research and research. Headquartered in Taizhou City, Jiangsu Province, the group has 15000 employees and covers an area of more than 3 million square meters. Its 15 member companies are distributed in Taizhou, Beijing, Shanghai, Nanjing, Guangzhou, Chengdu, Suzhou, Changzhou and other places; the marketing network covers all provinces, cities and autonomous regions except Taiwan. Yangzijiang Pharmaceutical Group takes R & D and innovation as the strategic basis of enterprise development, and is committed to the R & D of national first-class new drugs and innovative drugs. The Group continues to take the road of innovation. In terms of new drug research and development, the group comprehensively promotes the strategy of "three drugs simultaneously". It invests in new drug research and development at the proportion of 3-4% of sales every year, seizes the commanding point of science and technology, introduces high-end R & D and innovation talents with international vision, and establishes an international R & D system. At present, more than 100 chemical innovative drugs, generic drugs, traditional Chinese medicine and biological drugs are under research, ensuring the orderly development of short-term, medium-term and long-term products. After years of accumulation and innovation, the product system covers more than 10 fields, more than 10 dosage forms and more than 200 product specifications. The group has always been market-oriented. Its R & D products mainly focus on anti infection, cardio cerebrovascular and digestive system, and actively explore other drug markets with growth potential, forming a product echelon of "R & D, production and storage", which effectively ensures the sustainable and healthy development of the enterprise. The group has successfully developed and listed a large number of excellent TCM products with unique curative effects, such as Weisu granule, bieling Weitong granule, Lanqin oral liquid, Shuanghua Lily tablet, Xiangshao granule, bailemining capsule, Huangqi essence oral liquid, chaiqinqingning capsule, qingruxiao granule, Bushen Runfei oral liquid, Shenqu Xiaoshi oral liquid, according to the prescription of famous old TCM, such as academician Dong Jianhua, the leader of traditional Chinese medicine Countless patients sent health gospel. The longfengtang traditional Chinese medicine project under construction will focus on the technology of automatic pre-processing of traditional Chinese Medicine - Intelligent feeding - raw and auxiliary materials, unmanned transportation of finished products - robot stacking - automatic temperature control three-dimensional elevated warehouse storage, and strive to build a modern intelligent factory of traditional Chinese medicine. The development of the group does not forget to repay the society, and it has always been in the forefront of the whole society in disaster relief, poverty alleviation, supporting the army, education and various humanitarian relief activities for many years. The group has supported the selection of "Chinese medical science and Technology Award" for more than 16 years in a row, making great efforts to support the progress of medical science and technology in China. After the Wenchuan earthquake, Tianjin Port explosion and Yancheng tornado disaster, the Yangtze River donated money and goods for the first time. Facing the future, the striving Yangtze River Pharmaceutical Group takes the rejuvenation of national medicine as its own duty, with a scientific, rigorous and responsible attitude, and wholeheartedly serves the health of all mankind.

本文链接: https://brand.waitui.com/4682ce224.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

理想L7累计交付量突破30万辆

5月10日,理想汽车宣布,理想L7累计交付量突破300,000辆。(财联社)

26分钟前

“爱达·地中海号”邮轮首航深圳

5月9日,“爱达·地中海号”邮轮抵达深圳国际邮轮母港,并于当晚从深圳首航。今年秋季,“爱达·地中海号”将以深圳为母港运营特色航线,覆盖中国香港,以及日本、越南、菲律宾等目的地。爱达邮轮是中国邮轮自主品牌,其运营的国产大型邮轮“爱达·魔都号”也将于2026年在深圳首航。(e公司)

26分钟前

长春光机所光电突触器件研究取得新进展

中国科学院长春光学精密机械与物理研究所(下称“长春光机所”)的科研人员开发出一种紫外光电突触器件和一种光电突触晶体管,这两项成果分别为先进人工视觉系统和神经形态计算视觉的发展提供了新的技术路径。紫外光电突触器件由长春光机所特种发光科学与技术全国重点实验室黎大兵、孙晓娟研究员领导的研究团队成功开发。(e公司)

26分钟前

我国科学家实现基于主动光学强度干涉的合成孔径成像

中国科学技术大学潘建伟、张强、徐飞虎等人联合美国麻省理工学院、中国科学院西安光学精密机械研究所等单位,首次提出并实验验证了主动光学强度干涉技术合成孔径技术,实现了对1.36公里外毫米级目标的高分辨成像。实验系统的成像分辨率较干涉仪中的单台望远镜提升约14倍。该成果5月9日在国际学术期刊《物理评论快报》发表。(财联社)

26分钟前

中科海光杨鸿轩:医疗国产化进入实战期,好用比性能更重要

36氪获悉,在CHIMA 2025大会现场,中科海光副总裁杨鸿轩表示,医疗行业信息化进入实战阶段,对底层算力平台的要求不仅是性能强,更要“好用”和“易用”。海光高度重视生态链建设,联合超5000家产业链伙伴,从芯片、整机到操作系统、数据库、应用软件,构建了完整的产业生态体系,推动全场景应用适配。杨鸿轩指出,医疗行业专业信息化人手紧张,对平台“无感迁移”和“一站式支撑”的需求更高。他强调,海光将持续加大在医疗国产化领域的投入,携手生态伙伴深化技术协同与应用优化,助力医院构建稳健、高效的国产化信息系统基础。

26分钟前

本页详细列出关于护佑的品牌信息,含品牌所属公司介绍,护佑所处行业的品牌地位及优势。
咨询